L-2230.pdf

L-2230.pdf

L-2230.pdf

Powering Gene Therapy Breakthroughs From Discovery to Delivery With Streamlined Automated Protein Analytics

Analytical Instruments Gene Therapy CQAs

Powerful Analytical Tools

Capillary Electrophoresis (CE) Instruments Characterize viral vectors and assess vector purity and stability with Maurice™ Platforms, our fully integrated capillary electrophoresis (CE) systems that enable rapid analysis of charge and size heterogeneity and charge isoform fractionation.

Maurice and MauriceFlex Scan the QR Code or Visit: bio-techne.com/maurice

Simple Plex Simple Plex™ assays on the fully automated Ella™ platform offer a viable alternative to traditional plate-based ELISAs for rapid multiplex analysis, with enhanced precision, reproducibility, and wider dynamic ranges.

Simple Plex Ella Automated Immunoassays Scan the QR Code or Visit: bio-techne.com/simple-plex

Simple Western Simple Western™ Technology provides analytical-grade protein expression quantification in a multi-attribute platform approach, using just 3 µL of cell or tissue lysate sample.

Simple Western Technology Scan the QR Code or Visit: bio-techne.com/simplewestern

Our assortment of hands- free platforms provide you with consistent, high-quality data by automating sample handling and processing.

Reproducible, Trusted Data

Save precious AAV and Lentivirus samples by leveraging the sensitivity of ProteinSimple platforms. Get the data you need with as little as 3 µL of sample volume.

Stretch Your Samples Further

Be confident in your method performance and regulatory compliance by seamlessly transferring analytical methods between labs and across phases from discovery to manufacturing.

Easy Method Transfer

Generate 21 CFR Part 11 compliant data for streamlined preparation of CMC packages for regulatory submissions.

Data Digitalization

These platforms easily fit into your current workflows and adapt to your changing needs. No matter what throughput you require, results will be robust and reproducible—whether you're scaling up or scaling out.

Scale When You Need To

Get reproducible data faster with 90-minute ELISAs, 3-hour Western Analysis or 15-minute icIEF—all with hands-free operation.

Get Results Faster

Where Innovation Meets Simplicity

B IO

-T E

C H

N E

® // P O

W E

R IN

G G

E N

E T

H E

R A

P Y

B R

E A

K T

H R

O U

G H

S

0302

https://www.bio-techne.com/instruments/ice https://www.bio-techne.com/instruments/simple-plex https://www.bio-techne.com/instruments/simple-western

Addressing the Core Components of Quality from Discovery to Delivery

Stability Analysis • Product stability

• Aggregate formation

Identity Do I have the right virus in this product?

Are the VP ratios optimized to maximize infectivity?

Key Question

Viral type/subtype

Capsid protein ratio (VP ratios)

Attribute Detail

✓

✓

✓

✓

Simple Western

Simple Plex

Maurice

Stability Is my viral product stable? Product stability ✓

Purity Are there any protein contaminants in my product?

Can you estimate the empty/full status of my sample?

Process-related impurities

Host cell-related impurities

Capsid content (Empty/Full)

✓

✓

✓

✓

✓

✓

✓

✓

Potency How many viral particles do I have?

How well is my virus working?

How much protein is expressed after treatment?

Physical viral titer

Functional viral titer

Protein expression potency

✓

✓

✓

✓

Purity Analysis • Process-related impurities

• Host cell-related impurities

• Empty/full ratios

Potency Analysis • Physical & functional viral titer

• Transgene expression

Identity Analysis • In-process monitoring

• Serotype analysis

• Capsid protein ratios

Cutting Edge Analytical Technologies for Your Peace of Mind

0 4 05

B IO

-T E

C H

N E

® // P O

W E

R IN

G G

E N

E T

H E

R A

P Y

B R

E A

K T

H R

O U

G H

S

0 4

Validating viral identity is essential when selecting the right vector for targeted gene delivery. Different AAV serotypes vary in tropism and immunogenicity, and many individuals may have pre-existing immunity to certain serotypes.

As your workflows scale, traditional methods like SDS-PAGE, Western blotting, and mass spectrometry

Potency is one of the most critical quality attributes (CQAs) in gene therapy analysis—making reliable, high-performance assays essential.

Automated platforms for protein quantitation deliver faster results, greater reproducibility, and improved sample efficiency compared to traditional methods.

• In-process monitoring

• Serotype analysis

• Capsid protein ratios

Identity Confirmation Potency

Crude Sample Analysis: Simple Western For measuring complex samples, such as cell and tissue lysates, Simple Western provides reproducible AAV quantitation with 3 µL of sample required per well.

Supernatants, Purified Virus Preparations: Simple Plex Simple Plex assays on the Ella platform offer a fast, sensitive, and reproducible method for reliable viral capsid measurement. Simple Plex assays are available to quantify the viral titer of both lentivirus and adeno- associated virus capsids.

Pure Sample Analysis: Maurice For >70% pure samples, Maurice offers direct, highly sensitive measurements of capsid proteins, enabling one-day method development.

Crude Sample Analysis: Simple Western Simple Western technology provides fit-for-purpose protein expression potency assays, enabling efficient, simple, and inexpensive upstream and downstream process development.

Recommended Recommended

can become time-consuming bottlenecks due to their low throughput.

Switching to an automated method can streamline your process, providing high-resolution, reproducible data while using smaller sample volumes.

Identity is provided by an anti-VP1/2/3 antibody (orange), and purity by total protein (blue).

Assays use industry leading antibodies and correlate to ELISA. Detect only intact capsids with dynamic range of 3.6 logs.

Stacked profiles of four different AAV serotypes analyzed with the Turbo CE-SDS cartridge. Maurice CE-SDS assays identify different AAV serotypes.

Fit-for-purpose transgene protein expression with over 6,900 validated antibodies. Screen up to 96-samples in a little as 3 hours.

F I G U R E // 0 1

In-process monitoring of AAV serotypes with Simple Western

F I G U R E // 03

Physical viral titer with Simple Plex F I G U R E // 02

Serotype analysis with CE-SDS F I G U R E // 04

Protein expression potency with Simple Western

Viral Vector

12 40

C he

m ilu m in es ce

nc e P1

C hem

ilum inescence P2

0

100000

50000

0

100000

50000

0

100000

50000

0

100000

50000

MW (kDa)

30000 20000 10000 0

30000 20000 10000 0

30000 20000 10000 0

30000 20000 10000 0

66 116 230

Total Protein anti-VP1/2/3

AAV4

AAV7

VP3

VP3

VP2 VP1

AAV9

AAV1

VP2 VP1

Aggregate

0.8 1

Ab so rb an

ce

0

10

0

10

0

10

0

10

Relative Migration Time

Turbo CE-SDS VP3 IS

VP2VP1

1.2 1.4 1.6 1.8 2

AAV6

AAV8

AAV9

AAV1

0.05

Si gn

al (R

FU )

0.05

0.5

5

50

LLOQ

500

5000

Concentration (pg/mL) 0.5 5 50 500 5000 50000 500000

ULOQ

3

G FP

N or m al iz ed

A re a (lo

g)

2

4

6

8

AAV8 MOI (log vg/cell) 4 5 6 7

Lot 1 (Control) Lot 1 (Stressed) Lot 2 (Control) Lot 2 (Stressed)

Streamline assay transfer across teams and sites, accelerating development timelines and supporting consistent data generation at every stage.

B IO

-T E

C H

N E

® // P O

W E

R IN

G G

E N

E T

H E

R A

P Y

B R

E A

K T

H R

O U

G H

S

0706

Empty or partially filled AAV particles can compromise the purity and safety of gene therapy products. Traditional methods, such as analytical ultracentrifugation (AUC) and ELISAs, are often unreliable, lack sensitivity, and are difficult to scale for manufacturing.

Transitioning to an automated solution provides consistent and sensitive quantification of empty/full capsid ratios, with the scalability needed to support AAV manufacturing workflows.

Stability assessment is essential for ensuring that AAV vector particles retain their structural and functional integrity over time, helping to preserve potency, safety, and efficacy.

Purity Stability

Upstream Analysis: Simple Western For analysis of unpurified samples, Simple Western enables automated AAV empty/full ratio measurements in <6 hours.

Downstream Analysis: Maurice Save time, labor, and sample compared to AUC and get critical capsid content information with icIEF and CE-SDS using Maurice.

Host Cell Impurities: Simple Plex Simple Plex assays on the Ella platform offer a fast, sensitive, and reproducible method for reliable host cell impurity assessment.

Recommended

AAV Product Stability: Maurice Get high resolution AAV vector stability data with CVs <5% without dependence on particle size, using icIEF with Maurice.

Recommended

Detecting and quantifying residual proteins, such as host cell proteins (HCPs) from HEK293 cells or endonucleases from AAV vector preparations, is also critical for ensuring product purity.

High-sensitivity platforms are essential for identifying low levels of impurities that can affect efficacy, alter product quality, and potentially trigger immune responses in gene therapy applications.

Requires only 3 µL sample (~1012 GC/ml) per well. Applicable to multiple serotypes.

An increase in acidic species signifies deamidation, which in turn correlates with the transduction efficiency of AAVs.

Heat-stressed AAV8 shows substantial changes in its charge profile in as little as 7 days.

Low sample input (4x 1011 GC/mL), data in only 8 minutes.

Detect low levels of impurities as well as AAV genome residuals with only 8-minute separation.

F I G U R E // 07

Monitor deamidation of capsid proteins with icIEF

F I G U R E // 0 8

AAV stability assessment with intact icIEF methods

F I G U R E // 0 9

Stability profiling of capsid proteins with denatured icIEF methods

F I G U R E // 05

Rapid and sensitive empty/full capsid quantification with Simple Western

F I G U R E // 0 6

Impurity measurements with Maurice CE-SDS

Pe rc en

ta ge

(% )

0

100

50

% Empty or partially empty % Full

25%

75%

Ab so rb an

ce (m

AU )

4

3

2

1

0

Relative Migration Time 1 1.2 1.4 1.6 1.8 2 2.2 2.4 2.6

Turbo CE-SDSIS VP3

VP2 VP1

Impurities AAV Genome

AAV9-CMV-GFP scAAV9-hSyn-GFP AAV9-CK8-CAS9 scAAV9-CMV-GFP AAV9-CMV-Luciferase

Fl uo

re sc en

ce

pI value

T4W25C

T2W25C

T1W25C

VP3VP3dpI 4.05 pI 8.40T0 1000 2000

0

0 1000 2000

0 1000 2000

0 1000 2000

8.57.56.56 7 85.554.54

5.5 6

Fl uo

re sc en

ce

0 5000

pI 6.5 7

370C at 14 days

370C at 7 days

370C at 3 days

Control 40C

0

5000 0

5000 0

5000

6

Fl uo

re sc en

ce

pI 6.5 7.5

Reference

P2

P1 P3

P4P5

P6

1 Day

3 Days

8 Days

14 Days

7 0

5000

10000

0

5000

10000

0

5000

10000

0

5000

10000

0

5000

10000

0

Switching to a direct detection method offers greater sensitivity in less time, delivering robust stability data that can help streamline regulatory approvals.

B IO

-T E

C H

N E

® // P O

W E

R IN

G G

E N

E T

H E

R A

P Y

B R

E A

K T

H R

O U

G H

S

0908

Meet Our Instruments Scan the QR Code or Visit: bio-techne.com/instruments

Powering Your Research with Trusted Analytics

10,000+ Labs Trusting the Technology

4,500+ Citations

100+ Commercial Products Supported

• Automated Systems With Faster Results

• Reproducible Trusted Data

• Data Digitization Compliance

• Stretch Your Samples Further

• Easy Method Transfer

• Scale When You Need It

S P E C I F I C A T I O N S A T A G L A N C E

Platform Specifications

Main Sample Type

Assay Type

Detection Modes

Sample Volume

Assay Development

Detection Range (GC or VP/mL)

Runtime

Quantitative

Size Separation

Virus, cell, and tissue lysates

Western

Chemiluminescence, Fluorescence, Total protein

3 µL

Single antibody– open platform

109 - 1012

3 hours 5 hours with RePlex™

✓

✓

Simple Western

Virus lysates, supernatants, purified virus preparations

Sandwich ELISA

Fluorescence

25 µL

None– fully validated assay kits

106 - 1010

Less than 90 minutes

✓

Simple Plex

Virus preparation (>70% purity)

CE-SDS, icIEF and icIEF Fractionation

Absorbance and native fluorescence

50 µL

No antibody– open platform

1011 - 1014

5-35 minutes with CE-SDS 10-15 minutes with icIEF

✓

✓

Maurice

11

B IO

-T E

C H

N E

® // P O

W E

R IN

G G

E N

E T

H E

R A

P Y

B R

E A

K T

H R

O U

G H

S

10

https://www.bio-techne.com/instruments https://www.bio-techne.com/instruments/simple-western/one-sample-two-western-immunoassay-replex-jess-abby

Global info@bio-techne.com, bio-techne.com/find-us/distributors North America TEL 800 343 7475 Europe // Middle East // Africa TEL +44 (0)1235 529449 China info.cn@bio-techne.com, TEL 400.821.3475

For research use or manufacturing purposes only. Trademarks and registered trademarks are the property of their respective owners.

Contact Us

Global Developer, Manufacturer, and Supplier of High-Quality Reagents, Analytical Instruments, and Precision Diagnostics.

INCLUDES R&D Systems™ Novus Biologicals™ Tocris Bioscience™ ProteinSimple™ ACD™ ExosomeDx™ Asuragen® Lunaphore™

9491202644_0725


Item Type: pdf